Who
Alex M. Azar II
Director
Company insider
Files Form 4 as: Director, Guardant Health; Director, Hms Holdings; Sr. VP, Corp. Affairs & Comm., Eli Lilly and.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $300K
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 2 Jul 2007
- Last trade
- 14 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Sep – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 15 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $11K69 at $159.89 | filing |
| 12 Oct 2026filed 13 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —137 at $0.00 | filing |
| 12 Oct 2026filed 13 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —137 at $0.00 | filing |
| 16 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $145K826 at $175.00 | filing |
| 16 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $145K826 at $175.00 | filing |
| 12 Sep 2026filed 14 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,651 at $0.00 | filing |
| 12 Sep 2026filed 14 Sep 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,651 at $0.00 | filing |
| 12 Sep 2026filed 14 Sep 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,651 at $0.00 | filing |
| 12 Sep 2026filed 14 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,651 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —2,711 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —2,711 at $0.00 | filing |
| 12 Sep 2025filed 26 Sep 2025 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,532 at $0.00 | filing |
| 12 Sep 2025filed 26 Sep 2025 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,604 at $0.00 | filing |
| 30 Sep 2017filed 2 Oct 2017 | Hms Holdings | SEC FORM 4 Code A | $19K957 at $19.86 | filing |
| 21 Aug 2017filed 22 Aug 2017 | Hms Holdings | SEC FORM 4 Code A | —6,743 at $0.00 | filing |
| 21 Aug 2017filed 22 Aug 2017 | Hms Holdingsoption or derivative | SEC FORM 4 Code A | —6,743 at $0.00 | filing |
| 30 Jun 2017filed 5 Jul 2017 | Hms Holdings | SEC FORM 4 Code A | $15K811 at $18.50 | filing |
| 31 Mar 2017filed 4 Apr 2017 | Hms Holdings | SEC FORM 4 Code A | $15K738 at $20.33 | filing |
| 30 Dec 2016filed 3 Jan 2017 | Hms Holdings | SEC FORM 4 Code A | $13K728 at $18.16 | filing |
| 11 Nov 2016filed 14 Nov 2016 | Hms Holdings | SEC FORM 4 Code A | —7,057 at $0.00 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026Guardant Health (NASDAQ:GH) Director Sells $19,242.08 in StockGH · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Alex M. Azar II; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.